Gene therapy for antitumor vaccination

Methods in Molecular Biology

Volumn 542, Issue , 2009, Pages 515-527

  Kim Schulze, Seunghee ^a   Kaufman, Howard L ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Antitumor vaccination; melanoma; mmunotherapy; tumor antigen; vaccinia virus

Indexed keywords

VACCINIA VIRUS;

CANCER VACCINE;

ADOLESCENT; ADULT; ARTICLE; GENE THERAPY; HUMAN; IMMUNOLOGICAL MONITORING; IMMUNOLOGY; METHODOLOGY; NEOPLASM; ORGANIZATION AND MANAGEMENT; VACCINATION;

ADOLESCENT; ADULT; CANCER VACCINES; ELIGIBILITY DETERMINATION; GENE THERAPY; HUMANS; MONITORING, IMMUNOLOGIC; NEOPLASMS; VACCINATION;

EID: 67650309082     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-561-9_27     Document Type: Review

References (20)

1. Zippelius , A., Batard , P. Rubio-Godoy , V. Bioley , G. Lienard , F. Lejeune , D. Rimoldi , P. Guillaume , N. Meidenbauer , A. Mackensen , N. Rufer , N. Lubenow , D. Speiser , J. C. Cerottini , P. Romero , and M. J. Pittet.2004) Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance Cancer Res 64 , 2865-2873
2. Frumento , G. , T. Piazza , E. Di Carlo , and S. Ferrini.2006) Targeting tumor-related immunosuppression for cancer immunotherapy Endocr Metab Immune Disord Drug Targets 6 , 233-237
3. Gajewski , T. F.2000) Monitoring specific T-cell responses to melanoma vaccines: ELISPOT, tetramers, and beyond Clin Diagn Lab Immunol 7 , 141-144
4. Kaufman , H. , J. Schlom , and J. Kantor.1991) A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA) Int J Cancer 48 , 900-907
5. McAneny , D. , C. A. Ryan , R. M. Beazley , and H. L. Kaufman.1996) Results of phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with adVanced colorectal cancer Ann Surg Oncol 3 495-500
6. Zang , X. , and J. P. Allison.2007) The B7 family and cancer therapy: costimulation and coinhibition Clin Cancer Res 13 , 5271-5279
7. Hodge , J. , S. Abrams , J. Schlom , and J. Kantor.1994) Induction of antitumor immunity by recombinant vaccinia viruses expressingB7-1 or B7-2 costimulatory molecules Cancer Res 54 , 5552-5555
8. Horig , H. , D. S. Lee , W. Conkright , J. Divito , H. Hasson , M. LaMare , A. Rivera , D. Park , J. Tine , K. Guito , K. W. Tsang , J. Schlom , and H. L. Kaufman.2000) Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule Cancer Immunol Immunother 49 , 504-514
9. Hodge , J. W. , D. W. Grosenbach , A. N. Rad , M. Giuliano , H. Sabzevari , and J. Schlom.2001) Enhancing the potency of peptidepulsed antigen presenting cells by vector-driven hyperexpression of a triad of costimulatory molecules Vaccine 19 , 3552-3567
10. Hodge , J. W. , J. W. Greiner , K. Y. Tsang , H. Sabzevari , C. Kudo-Saito , D. W. Grosenbach , J. L. Gulley , P. M. Arlen , J. L. Marshall , D. Panicali , and J. Schlom.2006) Costimulatory molecules as adjuVants for immunotherapy Front Biosci 11 , 788-803
11. Kaufman , H. L. , S. Kim-Schulze , K. Manson , G. Deraffele , J. Mitcham , K. S. Seo , D. W. Kim , and J. Marshall.2007) Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer J Transl Med 5 , 60
12. Hodge , J. W. , H. Sabzevari , A. G. Yafal , L. Gritz , M. G. Lorenz , and J. Schlom.1999) A triad of costimulatory molecules synergize to amplify T-cell activation Cancer Res 59 , 5800-5807
13. Marshall , J. L. , R. J. Hoyer , M. A. Toomey , K. Faraguna , P. Chang , E. Richmond , J.E. Pedicano , E. Gehan , R. A. Peck , P. Arlen , K. Y. Tsang , and J. Schlom.2000) Phase I study in adVanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses J Clin Oncol 18 , 3964-3973
14. Tirapu , I. , E. Huarte , C. Guiducci , A. Arina , M. Zaratiegui , O. Murillo , A. Gonzalez , C. Berasain , P. Berraondo , P. Fortes , J. Prieto , M. P. Colombo , L. Chen , and I. Melero.2006) Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma Cancer Res 66 , 2442-2450
15. Kaufman , H. L. , G. DeRaffele , J. Mitcham , D. Moroziewicz , S. M. Cohen , K. S. Hurst- Wicker , K. Cheung , D. S. Lee , J. Divito , M. Voulo , J. DonoVan , K. Dolan , K. Manson , D. Panicali , E. Wang , H. Hörig , and F. M. Marincola.2005) Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma J Clin Invest 115 , 1903 - -1912
16. Kaufman , H. L. , S. Cohen , K. Cheung , G. DeRaffele , J. Mitcham , D. Moroziewicz , J. Schlom , and C. Hesdorffer.2006) Local delivery of vaccinia virus expressing multiple costimulatory molecules for the treatment of established tumors Hum Gene Ther 17 , 239-244
17. Kaufman , H. L. , W. Conkright , J. Divito , H. Horig , R. Kaleya , D. Lee , S. Mani , D. Panicali , L. Rajdev , T. S. Ravikumar , S. Wise-Campbell , and M. J. Surhland.2000) A phase I trial of intra lesional RV-B7.1 vaccine in the treatment of malignant melanoma Hum Gene Ther 11 , 1065-1082
18. Kaufman , H. L. , G. DeRaffele , J. Divito , H. Horig , D. Lee , D. Panicali , and M. Voulo.2001) A phase I trial of intralesional rVTricom vaccine in the treatment of malignant melanoma Hum Gene Ther 12 , 1459-1480
19. Panelli , M. C. , E. Wang , G. Phan , M. Puhlmann , L. Miller , G. A. Ohnmacht , H. G. Klein , and F. M. Marincola.2002) Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration Genome Biol 3 , RESEARCH0035
20. Panelli , M. C. , E. Wang , V. Monsurro , and F. M. Marincola.2002) The role of quantitative PCR for the immune monitoring of cancer patients Expert Opin Biol Ther 2 , 557-564